Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer-Reference-Cited by-同舟云学术

Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer

Published:2016-05-04 Issue:26 Volume:55 Page:7520-7524
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Cao Yu¹,Rodgers David T.²,Du Juanjuan²,Ahmad Insha¹,Hampton Eric N.²,Ma Jennifer S. Y.²,Mazagova Magdalena²,Choi Sei-hyun¹³,Yun Hwa Young¹,Xiao Han¹,Yang Pengyu²,Luo Xiaozhou¹,Lim Reyna K. V.²,Pugh Holly M.²,Wang Feng²,Kazane Stephanie A.²,Wright Timothy M.²,Kim Chan Hyuk²⁴,Schultz Peter G.¹²,Young Travis S.²

Affiliation:

1. Department of Chemistry and The Skaggs Institute for Chemical Biology; The Scripps Research Institute; 10550 N Torrey Pines Rd La Jolla CA 92037 USA

2. California Institute for Biomedical Research; 11119 N Torrey Pines Rd La Jolla CA 92037 USA

3. Present address: Daegu-Gyeongbook Medical Innovation Center; 80 Chembok-ro Dong-gu Daegu 41061 Korea

4. Present address: Department of Biological Sciences, Korea Advanced Institute of Science and Technology; 291 Daehak-ro Yuseong-gu Daejeon 34141 Korea

Funder

NIH

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference30 articles.

1. Chimeric Antigen Receptor Therapy for Cancer

2. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor

3. Adoptive immunotherapy for cancer: harnessing the T cell response

4. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

5. Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling;Molecular Therapy: Oncology;2024-09

2. Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells;Antibodies;2024-06-07

3. Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies;Frontiers in Immunology;2024-06-03

4. In vivo manufacture and manipulation of CAR-T cells for better druggability;Cancer and Metastasis Reviews;2024-04-09

5. Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies;Breast Cancer Research;2024-03-29